Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

686 ARTÍCULOS , VIENDO DEL 91 AL 105

Physical Exercise as a Nonpharmacological Intervention for the Treatment of Neuropsychiatric Symptoms in Persons With Dementia: A Meta-analysis of Randomized Controlled Trials

Kouloutbani K, Venetsanou F, Karteroliotis KE, Politis A.

Alzheimer Dis Assoc Disord. 2023 Jan-Mar 01;37(1):73-81. doi: 10.1097/WAD.0000000000000544. Epub 2023 Feb 13.

Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer's Disease?

Mills ZB, Faull RLM, Kwakowsky A.

Int J Mol Sci. 2023 Feb 6;24(4):3205. doi: 10.3390/ijms24043205.

Hot Spots for the Use of Intranasal Insulin: Cerebral Ischemia, Brain Injury, Diabetes Mellitus, Endocrine Disorders and Postoperative Delirium

Shpakov AO, Zorina II, Derkach KV.

Int J Mol Sci. 2023 Feb 7;24(4):3278. doi: 10.3390/ijms24043278.

Support Provided by Caregivers for Community-Dwelling Diabetic Hispanic Adults with Intellectual Disabilities and Comorbid Conditions

Rawat P, Sehar U, Bisht J, Reddy PH.

Int J Mol Sci. 2023 Feb 14;24(4):3848. doi: 10.3390/ijms24043848.

State Variation in Antipsychotic Use Among Assisted Living Residents With Dementia

Zhang T, Thomas KS, Zullo AR, Coe AB, Gerlach LB, Daiello LA, Varma H, Lo D, Joshi R, Bynum JPW, Shireman TI.

J Am Med Dir Assoc. 2023 Apr;24(4):555-558.e1. doi: 10.1016/j.jamda.2023.01.014. Epub 2023 Feb 23.

A Long-term Study of NeuroAid (MLC601, MLC901) in Patients with Alzheimer's Disease; An Extension 8-year Follow-up Study

Pakdaman H, Amini Harandi A, Gharagozli K, Siavoshi F, Shirzadeh Barough S, Sharifipour E, Esfandani A, Ilkhani S, Tabatabaei FS, Sobhanian SA.

Curr Aging Sci. 2023;16(3):234-239. doi: 10.2174/1874609816666230224111759.

Alzheimer's disease and COVID-19: Interactions, intrinsic linkages, and the role of immunoinflammatory responses in this process

Li W, Sun L, Yue L, Xiao S.

Front Immunol. 2023 Feb 9;14:1120495. doi: 10.3389/fimmu.2023.1120495. eCollection 2023.

Hippocampal Vascular Supply and Its Role in Vascular Cognitive Impairment

Johnson AC.

Stroke. 2023 Mar;54(3):673-685. doi: 10.1161/STROKEAHA.122.038263. Epub 2023 Feb 27.

Cardiovascular disease risk burden and cognitive impairment

Chen LK.

Arch Gerontol Geriatr. 2023 May;108:104966. doi: 10.1016/j.archger.2023.104966. Epub 2023 Feb 20.

Complementary and Alternative Medicine Approaches in Alzheimer Disease and Other Neurocognitive Disorders

Beversdorf DQ, Crosby HW, Shenker JI.

Mo Med. 2023 Jan-Feb;120(1):70-78.

Development of a home-based cognitive test for cognitive monitoring in subjective cognitive decline with high risk of Alzheimer's disease

Hong YJ, Lee SB, Kim SH, Lee MA, Park JW, Yang DW.

Medicine (Baltimore). 2023 Mar 3;102(9):e33096. doi: 10.1097/MD.0000000000033096.

Low Threshold for Laparoscopic Exploration in Dementia Patients With Unexplained Abdominal Pain and Risk Factors for Acute Mesenteric Ischemia

Vakil DP, Shumway MC, Spector CL, Carrillo EH, Rosenthal A.

Am Surg. 2023 Aug;89(8):3514-3515. doi: 10.1177/00031348231161719. Epub 2023 Mar 3.

Targeting cerebral small vessel disease to promote healthy aging: Preserving physical and cognitive functions in the elderly

Chung CP, Ihara M, Hilal S, Chen LK.

Arch Gerontol Geriatr. 2023 Jul;110:104982. doi: 10.1016/j.archger.2023.104982. Epub 2023 Feb 26.

Predictors of cognitive deterioration in subjective cognitive decline: evidence from longitudinal studies and implications for SCD-plus criteria

Li H, Tan CC, Tan L, Xu W.

J Neurol Neurosurg Psychiatry. 2023 Oct;94(10):844-854. doi: 10.1136/jnnp-2022-330246. Epub 2023 Mar 3.

Unlocking Modifiable Risk Factors for Alzheimer's Disease: Does the Oral Microbiome Hold Some of the Keys?

Loughman A, Adler CJ, Macpherson H.

J Alzheimers Dis. 2023;92(4):1111-1129. doi: 10.3233/JAD-220760.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias